Cargando…
Developing solid oral dosage forms : pharmaceutical theory and practice /
This book is intended for pharmaceutical professionals engaged in research and development of oral dosage forms. It covers essential principles of physical pharmacy, biopharmaceutics and industrial pharmacy as well as various aspects of state-of-the-art techniques and approaches in pharmaceutical sc...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston ; London :
Academic,
2009.
|
| Edición: | 1st ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn316577504 | ||
| 003 | OCoLC | ||
| 005 | 20231117015300.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 090320s2009 ne a ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d BTCTA |d BAKER |d YDXCP |d OCLCQ |d N$T |d E7B |d OCLCQ |d OHS |d OCLCO |d CHVBK |d OCLCQ |d D6H |d LOA |d IDEBK |d TJC |d OCLCO |d ICA |d YDX |d N$T |d OCLCO |d AGLDB |d LVT |d COCUF |d K6U |d PIFAG |d FVL |d OCLCQ |d U3W |d NLE |d KIJ |d OCLCO |d OCLCF |d VNS |d OCLCO |d VTS |d CASUM |d STF |d WRM |d OCLCO |d AU@ |d OCLCO |d OCLCA |d LEAUB |d UKCRE |d AJS |d OCLCO |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 229026098 |a 373506882 |a 646808685 |a 962188723 |a 962753327 |a 972078823 |a 992053793 |a 1004968476 |a 1043506329 |a 1086946978 |a 1153544830 | ||
| 020 | |a 9780080932729 |q (electronic bk.) | ||
| 020 | |a 008093272X |q (electronic bk.) | ||
| 020 | |z 9780444532428 | ||
| 020 | |z 0444532420 | ||
| 035 | |a (OCoLC)316577504 |z (OCoLC)229026098 |z (OCoLC)373506882 |z (OCoLC)646808685 |z (OCoLC)962188723 |z (OCoLC)962753327 |z (OCoLC)972078823 |z (OCoLC)992053793 |z (OCoLC)1004968476 |z (OCoLC)1043506329 |z (OCoLC)1086946978 |z (OCoLC)1153544830 | ||
| 050 | 4 | |a RS201.S57 |b D48 2009eb | |
| 060 | 4 | |a QV 787 D489 2009 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.19 |2 22 |
| 245 | 0 | 0 | |a Developing solid oral dosage forms : |b pharmaceutical theory and practice / |c executive editors, Yihong Qiu, Yisheng Chen, Geoff G.Z. Zhang ; associate editors, Linong Liu, William R. Porter. |
| 250 | |a 1st ed. | ||
| 260 | |a Amsterdam ; |a Boston ; |a London : |b Academic, |c 2009. | ||
| 300 | |a 1 online resource (xxx, 943 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This book is intended for pharmaceutical professionals engaged in research and development of oral dosage forms. It covers essential principles of physical pharmacy, biopharmaceutics and industrial pharmacy as well as various aspects of state-of-the-art techniques and approaches in pharmaceutical sciences and technologies along with examples and/or case studies in product development. The objective of this book is to offer updated (or current) knowledge and skills required for rational oral product design and development. The specific goals are to provide readers with: Basics of modern theories of physical pharmacy, biopharmaceutics and industrial pharmacy and their applications throughout the entire process of research and development of oral dosage forms. Tools and approaches of preformulation investigation, formulation/process design, characterization and scale-up in pharmaceutical sciences and technologies. New developments, challenges, trends, opportunities, intellectual property issues and regulations in solid product development The first book (ever) that provides comprehensive and in-depth coverage of what's required for developing high quality pharmaceutical products to meet international standards. It covers a broad scope of topics that encompass the entire spectrum of solid dosage form development for the global market, including the most updated science and technologies, practice, applications, regulation, intellectual property protection and new development trends with case studies in every chapter. A strong team of more than 50 well-established authors/co-authors of diverse background, knowledge, skills and experience from industry, academia and regulatory agencies. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Ch 1Solubility of Pharmaceutical Solids; Ch 2Crystalline and Amorphous Solids; Ch 3Analytical Techniques in Solid State Characterization; Ch 4Salt Screening and Selection: New Challenges and Considerations in the Modern Pharmaceutical R & D Paradigm; Ch 5Drug Stability and Stability Studies; Ch 6Excipient Compatibility; Ch 7Theory of Diffusion and Pharmaceutical Applications; Ch 8Particle, Powder and Compact Characterization; Ch 9Polymer Properties and Characterization; Ch 10Applied Statistics in Product Development; Ch 11Oral Absorption Basics: Pathways, Physicochemical and Biological Factors, and Methods of Study; Ch 12Oral Absorption Evaluation and Prediction; Ch 13Fundamentals of Dissolution; Ch 14Dissolution Testing of Solid Products; Ch 15Bioavailability and Bioequivalence; Ch 16In Vivo Evaluation of Dosage Form Performance; Ch 17In Vitro-In Vivo Correlations: Fundamentals, | |
| 505 | 0 | |a Applications and Development Considerations; Ch 18Integration of physical, chemical, mechanical and biopharmaceutical properties in solid oral dosage form development; Ch 19 Design and Development of Self-Emulsifying Drug Delivery Systems for Enhanced Oral Absorption of Poorly Soluble Compounds; Ch 20Rational Design of Oral Modified-Release Drug Delivery Systems; Ch 21Development of Modified-Releas Oral Dosage Forms; Ch 22Analytical Development and Validation for Solid Oral Dosage Forms; Ch 23Statistical Design and Analysis of Long Term Stabilty Studies for Drug Products; Ch 24Packaging selection for solid dosage forms; Ch 25 Clincial Supplies Manufacture; Ch 26Specification Setting and Manufacturing Process Control for Solid Oral Drug Products; Ch 27Scale-Up Of Pharmaceutical Manufacturing Operation of Solid Dosage Forms; Ch 28 Process Development, | |
| 505 | 0 | |a Optimization and Scale-Up: Powder Handling and Segregation Concerns; Ch 29Process Development and Scale-Up of Wet Granulation by High-Shear Process; Ch 30Development, Scale-Up and Optimization of Fluid-bed Granulation; Ch 31Development, Optimization and Scale-Up of Process Parameters: Roller Compaction; Ch 32Development, Optimization And Scale-Up Of Process Parameters: Compression; Ch 33Development, Optimization & Scale-Up of Process Parameters: Pan Coating; Ch 34Development, Optimization And Scale-Up Of Process Parameters: Wurster Coating; Ch 35Process Analytical Technology; Ch 36 The Product Development Process; Ch 37Product Registration and Drug Approval Process; Ch 38Modern Pharmaceutical Development Regulations; Ch 39Intellectual Property in Pharmaceutical Development; Ch 40Product Life-Cycle Management | |
| 650 | 0 | |a Solid dosage forms. | |
| 650 | 0 | |a Solid dosage forms |x Research. | |
| 650 | 0 | |a Drugs |x Dosage forms. | |
| 650 | 0 | |a Oral medication. | |
| 650 | 2 | |a Dosage Forms |0 (DNLM)D004304 | |
| 650 | 2 | |a Administration, Oral |0 (DNLM)D000284 | |
| 650 | 6 | |a M�edicaments |x Formes pharmaceutiques solides. |0 (CaQQLa)201-0096464 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0096464 |x Formes pharmaceutiques solides |0 (CaQQLa)201-0096464 |x Recherche. |0 (CaQQLa)201-0379425 | |
| 650 | 6 | |a M�edicaments |x Formes pharmaceutiques. |0 (CaQQLa)201-0025596 | |
| 650 | 6 | |a M�edicaments |x Administration par voie orale. |0 (CaQQLa)201-0111888 | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Oral medication |2 fast |0 (OCoLC)fst01047087 | |
| 650 | 7 | |a Drugs |x Dosage forms |2 fast |0 (OCoLC)fst00898801 | |
| 650 | 7 | |a Solid dosage forms |2 fast |0 (OCoLC)fst01125411 | |
| 650 | 7 | |a L�akemedel. |2 sao | |
| 650 | 7 | |a L�akemedelstillverkning. |2 sao | |
| 700 | 1 | |a Qiu, Yihong |c (Writer on solid dosage forms) | |
| 700 | 1 | |a Chen, Yisheng. | |
| 700 | 1 | |a Zhang, Geoff G. Z. | |
| 776 | 0 | 8 | |i Print version: |t Developing solid oral dosage forms. |b 1st ed. |d Amsterdam ; Boston ; London : Academic, 2009 |z 9780444532428 |z 0444532420 |w (OCoLC)260206308 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780444532428 |z Texto completo |